Subject Index A sensitization to, 135 airborne contact urticaria, 127-128 Acariasis, differential diagnosis of, 170-171 Acrylic acid, sensitization to, 135 airborne irritant contact dermatitis Acaricides Acrylic resins anhydrite dermatitis, 125-126 chemical classification of, 176 chemistry of, 134-135 dermatitis from miscellaneous in patch testing, 181 clinical features of, 135 agents, 126-127 Acetic acid industrial use of, 135 fiberglass dermatitis, 125 in irritant contact dermatitis, 158 patch testing and, 136, 138 slag dermatitis, 126 in nonallergic contact urticaria, 206 personal data for, 137-138 trona dermatitis, 125 Acetone, in paint products, 186 sensitization to, 135 airborne photoallergic contact Acetylcholine, in contact urticaria, 160 Acrylics dermatitis, 127 Acetylsalicyclic acid, in immunologic in immunologic contact urticaria, 206 airborne phototoxic contact dermatitis, contact urticaria, 206 in paint products, 186 127 Acidic fibroblast growth factor (aFGF), in Acrylonitrile chloracne, 128 endothelial cell stimulation, 379 industrial use of, 135 classification of, 124 Acids, in airborne contact dermatitis, 125 in melanoma, 52 diagnosis of, 129 ACLE, see Acute cutaneous lupus Actinic cheilitis, 5-fluororacil for, 306 differential diagnoses of, 124 erythematosus Actinic keratoses, 5-fluororacil for, 306- mixed forms of, 129 Acne, occupational 307 nature of airborne contactants chloracne, 214-215 Actinic poikilodermia, in xeroderma droplets, 123 diagnosis of, 216 pigmentosum, 83 solid biologic particles, 123 histology of, 216 Actinic prurigo, differential diagnosis of, solid nonbiologic particles, 123 less commmon forms of, 215-216 170 vapors, gases, and smoke, 123 oil and coal tar acne, 213-214 Acute cutaneous lupus erythematosus paresthesias, 128 therapy for, 216 (ACLE), skin lesions in, 390 plants in, 160 Aconitus spp., in irritant contact Acyclovir, prior to cold steel surgery, 267, predisposing physical factors, 123 dermatitis, 158 270 prevention of, 129 Acquired immunodeficiency syndrome Adipocyte lipids, in endothelial cell skin symptoms of, 124-125 (AIDS) stimulation, 379 therapy for, 129 melanoma in, 18, 71 Adipose tissue deformities, Airborne contact urticaria, in workplace posttraumatic, liposuction in characterization of, 127-128 epidemiology of, 201 lessening of visibility of, 370 Airborne phototoxic contact dermatitis, history of, 201 Adiposis dolorosa, liposuction for, 369 characterization of, 127 risk of acquiring HIV infection at Adrenaline, in topical anesthesia, 279 Aircraft industry, melanoma work, 201-202 aFGF, see Acidic fibroblast growth factor development correlated with risk of transmitting HIV infection at Africa, melanoma in, 56 occupation in, 53 work, 202-203 Age Alachlor, in patch testing, 181 toxicity of work to HIV-infected in melanoma, 17 Alantolactone, in allergic contact workers, 203 in scleroderma, 409, 411 dermatitis, 161, 163 Acrochordons, electrosurgery for, 287 AIDS, see Acquired immunodeficiency Albinism, in melanoma, 84-86 Acrylamide, industrial use of, 135-136, syndrome Alcohols 138 Airborne atopic dermatitis, in immunologic contact urticaria, 206 Acrylated epoxy resins characterization of, 128 in melanoma, 80 industrial use of, 135 Airborne contact dermatitis in nonallergic contact urticaria, 206 sensitization to, 135 airborne allergic contact dermatitis, Alcyonidium gelatinosum, in airborne Acrylates 126-127 contact dermatitis, 127 industrial use of, 135 airborne atopic dermatitis, 128 Alcynodium spp., in photodermatitis, 238 © 1993 by Elsevier Science Publishing Co., Inc. - 0738-081x/93/$6.00 483 484 SUBJECT INDEX Clinics in Dermatology 1993 ;10:483-504 Algae p-Aminobenzoic acid, in photodermatitis, Annular atrophic plaques, immunologic in immunologic contact urticaria, 207 237 findings in, 403 in photodermatitis, 238 Aminoglycoside antibiotics, in Anthracene, in photodermatitis, 237-238 Aliphatic chloroacids, chemical occupational drug dermatitis, 142 Anthracycline antibiotics, in occupational classification of, 177 Aminophenazone, in immunologic drug dermatitis, 143 Aliphatic polyamine, in immunologic contact urticaria, 206 Anthraquinone, in photodermatitis, 238 contact urticaria, 206 p-Aminophenol, triglycidyl derivative of, Anthrax, as occupational cutaneous Alkalis, in airborne contact dermatitis, sensitization to, 134 infection, 225 125-126 Aminophylline, in occupational drug Antibiotics Alkylcatechols, in allergic contact dermatitis, 143 in cold steel surgery, 267 dermatitis, 159 Aminoquinolines, in occupational drug in immunologic contact urticaria, 206 Allergic contact dermatitis dermatitis, 142 in melanoma, 58 afferent phase of, 115-116 Aminothiazole, in immunologic contact Anticentromere antibody distribution of by type, 151 urticaria, 206, 209 Scl 70 antibody and, 411-412 efferent phase of, 116-117 Amitriptyline, in photodermatitis, 237 in systemic scleroderma, 408-413, 415 future research on, 245-246 Amitrole, in patch testing, 181 Antiepileptics, in occupational drug immunoregulation in, 117 Ammi maius, in photodermatitis, 160 dermatitis, 141 in patch testing, 195-199 Ammonia Antigen presenting cells, in allergic pesticides in, 179 in airborne contact dermatitis, 126 contact dermatitis, 115-116 plants in, 158-160 in immunologic contact urticaria, 206 Antigens, melanoma, 69-70 predisposing factors to, 246 Ammonium nitrate, in photodermatitis, Antihelminthics, in occupational drug prevention of, 245-246 238 dermatitis, 143 rubber in, 149-150 Amniotic fluid, in immunologic contact Antihistamines Allergic reactions, as sclerotherapy urticaria, 207 in melanoma, 57 complication, 374 d-Amphetamine, in melanoma, 57 in occupational drug dermatitis, 141- Allergic skin tests, in diagnosis of allergic Ampicillin, in occupational drug 142 contact dermatitis, 196-197 dermatitis, 142 Antihypertensive drugs, in occupational Allium spp., in allergic contact dermatitis, Amylocaine, in occupational drug drug dermatitis, 142 159-160 dermatitis, 141 Antimalarials, in occupational drug Alpha-adrenergic blocking agents, in Anaphylaxis, as sclerotherapy dermatitis, 142 occupational drug dermatitis, 142 complication, 374 Antimicrobials, in occupational drug Alphadolone, in occupational drug Anacardiaceae, in allergic contact dermatitis, 142 dermatitis, 141 dermatitis, 159-160 Antinuclear antibodies Alphaxalone, in occupational drug Anemone spp., in irritant contact in collagen diseases, 423-425 dermatitis, 141 dermatitis, 158 in localized scleroderma, 416 Alprenolol, in occupational drug Anesthesia in relatives of systemic scleroderma dermatitis, 142 in liposuction, 365-367 patients, 415 Alstroemeria ligtu, in plant dermatitis, 157, local, 275-281 in systemic scleroderma, 407- 163 in nail surgery, 327 408, 414 Althesin, in occupational drug dermatitis, in occupational drug dermatitis, 141 Antinucleolar antibodies, in 141 in punch hair transplantation, 337-338 scleromyositis, 458 Aluminum hydroxide, in occupational in scalp reduction, 347-348 Antioxidants, dietary, for skin granuloma, 222 in suction-assisted lipectomy, 361 melanoma, 79-80 Aluminum powder, in airborne contact Angiogenesis, sclerotherapy and, Antiphospholipid antibodies, in dermatitis, 125 378-379 systemic lupus erythematosus, Amaryllidiaceae, in allergic contact Angiogenin, in endothelial cell 391 dermatitis, 160 stimulation, 379 Antiproliferative agents, in Ambrosia spp., in allergic contact Angiokeratomas, electrotherapy for, 289 occupational drug dermatitis, 142- dermatitis, 158, 160 Angry back syndrome 143 Ambulatory phlebectomy, in irritant contact dermatitis, 118 Antipsychotic drugs, in characterization of, 374 in patch testing, 198 occupational drug dermatitis, 143 Amethocaine, in occupational drug Anhydrite dermatitis, as airborne irritant Anti-Ro syndromes, classification dermatitis, 141 contact dermatitis, 125-126 of, 390 Amide anesthetics Anilides, chemical classification of, 176 Anti-single-stranded DNA adverse reactions to, 281 Animal feeds antibodies, in localized in infiltrative anesthesia, 279 in airborne allergic contact dermatitis, scleroderma, 417 Amides, in paint products, 186 126 Antithyroid drugs, in Amikacin, in occupational drug in occupational drug dermatitis, 144 occupational drug dermatitis, 143 dermatitis, 142 Animals Antitussive agents, in Amine hardeners, in patch testing, 134 immunologic contact urticaria in, 207 occupational drug dermatitis, 143 Amino-acyl-tRNA synthetases, melanoma in, 71-72 Antu, in patch testing, 181 autoantibodies to, 461-470 nonallergic contact urticaria in, 206 AP-1 complex, in melanoma, 35 Clinics in Dermatology SUBJECT INDEX 485 1993;10:483-504 Apomorphine, in occupational drug Azoxybenzenes, in chloracne, 128 Benzoyl peroxide dermatitis, 143 Azynphos-methyl, in patch testing, 180 in immunologic contact urticaria, 206 Apothesin, in occupational drug in melanoma, 54, 58-59 dermatitis, 141 B in patch testing, 136, 138 Aquagenic urticaria, characterization of, Bacitracin, in immunologic contact sensitization to, 135 206 urticaria, 206 Benzyl alcohol, in infiltrative anesthesia, Aquarium granuloma, as occupational Balsam of Peru 280 cutaneous infection, 227 in contact urticaria, 160 Benzyl ketone, in paint products, 186 Araceae, in irritant contact dermatitis, in nonallergic contact urticaria, 206 Benzylpenicillin, in occupational drug 160 in patch testing, 138, 197 dermatitis, 142 Araliaceae, in allergic contact dermatitis, percentage incidence of, 151 Berberis dermatitis, differential diagnosis 160 sensitization to, 150 of, 170-171 Arnica tincture, as plant allergen, 161 Barban, in patch testing, 181 Berberis vulgaris, in dermatitis, 171 Aromatic amines, in melanoma, 57 Barber’s hair sinus, as occupational Bergapten, in photodermatitis, 160 Aromatic chlorinated hydrocarbons, in dermatitis, 221 Beryllium, in occupational skin chloracne, 128 Barrier creams granuloma, 220 Arsenic for fiberglass dermatitis, 173 Beta blockers, in occupational drug in airborne contact dermatitis, 125 for occupational contact dermatitis, dermatitis, 142 in melanoma, 59 191-192, 208 B-carotene, for melanoma, 80 Arthritis, in scleroderma, 409, 411 Basal cell carcinoma bFGF, see Basic fibroblast growth factor Arthropods, in nonallergic contact electrosurgery for, 287-288 BGE, see n-Butyl glycidyl ether urticaria, 206 5-fluororacil for, 306 BHT, see Butylated hydroxytoluene Ascorbic acid, for melanoma, 80 Mohs micrographic surgery for, 314- Bilobed flap modifications, in cold steel Asia, melanoma in, 17 315 surgery, 268 Atopy, in irritant contact dermatitis, 117, photodynamic laser therapy for, 298 Biological response modifier therapy, for 118 toluidine blue stain for, 314-315 melanoma, 108, 323-324 Atranorin Basal cell nevus syndrome, Birch wood, in immunologic contact in allergic contact dermatitis, 159, 161 photodynamic laser therapy for, urticaria, 207 in photodermatitis, 160 298 Bisected grafting, in punch hair Atrazine, in patch testing, 181 Basic fibroblast growth factor (bFGF), in transplantation, 336 Atrophoderma Pasini Pierini, endothelial cell stimulation, 379 Bisphenol A antinuclear antibodies in, 416-417 Basophils, in allergic contact dermatitis, chemistry of, 133 Atypical cutaneous lupus, 117 in patch testing, 134 characterization of, 389 Basting suture, in cold steel surgery, 270 sensitization to, 134 Atypical nevi, clinical characteristics of, Bayo-N-OX-I, in occupational drug Bisulfites, in adverse anesthesia reactions, 22 dermatitis, 143 281 Australia Becker’s nevus, Q-switched ruby laser Bitumen, in paint products, 186 giant congenital nevi in, 26 therapy for, 296 Black heel, characterization of, 232 melanoma in, 1, 2, 9, 16-17, 41, 43-46, Benign lesions Blacks 48, 75-78, 80, 91-92, 95, 107 copper vapor laser therapy for, 295 melanoma in, 17, 56 Austria, melanoma in, 85 electrosurgical removal of, 287-288 xeroderma pigmentosum in, 83 Autoimmune thrombocytopenic photodynamic laser therapy for, 298 Bleomycin purpura, as anti-Ro syndrome, Benomyl, in patch testing, 180 for keratoacanthomas, 384 390 Benzocaine for warts, 384-385 Autoimmunity in nonallergic contact urticaria, 206 Blood, in immunologic contact urticaria, in collagen diseases, 396 in occupational drug dermatitis, 141, 207 retroviruses in induction of, 407 143 Bone marrow transplantation, melanoma in systemic lupus erythematosus, 391 in patch testing, 197 risk correlated with, 83 Autolase scanner, computerized, 292, 295 in photodermatitis, 237 Border effect, in patch testing, 198 Autologous fat transplantation, for sensitization to, 150 Bougainvillea, in immunologic contact correction of soft tissue defects, in topical anesthesia, 277 urticaria, 207 370-371 Benzodiazepines, in occupational drug Bowen’s disease Axillary hyperhidrosis dermatitis, 143 5-fluororacil for, 306 case studies of, 361, 364 Benzoic acid nail surgery in, 328 Grazer suction-assisted lipectomy in immunologic contact urticaria, 206 photodynamic laser therapy for, 298 procedure for, 359-363 in nonallergic contact urticaria, 206 Brain, melanoma metastasis to, 323 history of treatment for, 358 Benzophenone, in immunologic contact Brassica spp., in irritant contact liposuction for, 369 urticaria, 206 dermatitis, 158, 160 sweat gland anatomy and, 357-358 Benzopyrene, in photodermatitis, 237 Breast cancer Tord Skoog surgical procedure for, Benzothiazole derivatives, in FAMM syndrome correlated with, 358-359 occupational contact dermatitis, 24 Azobenzenes, in chloracne, 128 153 photodynamic laser therapy for, 298 486 SUBJECT INDEX Clinics in Dermatology 1993 ;10:483-504 Bromelain, in irritant contact dermatitis, Candela laser, see Pigmented lesion CD2 molecule, in allergic contact 158 pulsed dye laser dermatitis, 116 Brucellosis, as occupational cutaneous Candidiasis, as occupational cutaneous CDLE, see Chronic disseminated discoid infection, 225-226 infection, 227-228 lupus erythematosus Bryozoa Cannulas, in liposuction, 366-368 Celery, in photodermatitis, 238 in airborne allergic contact dermatitis, Caoutchouc, in rubber synthesis process, Cellosolve acetate, in paint products, 186 126-127 149 Cellulose in photodermatitis, 238 Capparis spinosa, in irritant contact in airborne contact dermatitis, 126 Buffalo hump, liposuction for, 369 dermatitis, 158 in paint products, 186 Bumetonide, in occupational drug Capsicum tincture, as plant allergen, 161 Cement, in airborne contact dermatitis, dermatitis, 143 Captafol (Difolatan) 125-126 Bupivicaine in contact dermatitis, 179 Central involvement, in scleroderma, 409, classification and clinical in patch testing, 180 411 pharmacology of, 276 Captan Central nervous system (CNS) disease, in infiltrative anesthesia, 279 in contact dermatitis, 179 systemic lupus erythematosus as, prior to punch hair transplantation, in patch testing, 180 390 338 Carbamate derivatives, nitrosourea Central nervous system (CNS) Burow’s triangle, excision of, 270, 331 group, in occupational drug stimulants, in occupational drug Butanediol diacrylate, in patch testing, dermatitis, 142 dermatitis, 143 136 Carbamates, in airborne allergic contact Cephalosporins Butanediol dimethacrylate, in patch dermatitis, 126 in immunologic contact urticaria, 206 testing, 136 Carbamezapine, in occupational drug in occupational drug dermatitis, 142 Butchers’ warts, as occupational dermatitis, 141 c-erb oncogene, in melanoma, 35-37 cutaneous infection, 229 Carbamic mix, sensitization to, 150 Cervical cancer, 5-fluororacil for, 306 Butterflies, in airborne allergic contact Carba mix, in patch testing, 197 c-fos oncogene, in melanoma, 35-36 dermatitis, 128 Carbaryl, in patch testing, 180 o-CGE, see o-Cresylglycidyl ether Butyl acrylate Carbimazole Chemical agents in paint products, 186 in occupational drug in immunologic contact urticaria, 206 in patch testing, 136, 138 dermatitis, 143 in melanoma, 59 Butyl alcohol, in paint products, 186 in photodermatitis, 238 Chemical peels Butylated hydroxytoluene (BHT) Carbocromen, in occupational characterization of, 257 in immunologic contact urticaria, 206 drug dermatitis, 143 for scar improvement, 381 for melanoma, 80 Carbon dioxide laser, Chemists, melanoma development n-Butyl glycidyl ether (BGE) superpulsed, characterization of, among, 53 in patch testing, 134, 137 291-292 Chemosurgery personal data for, 136 Carbon dioxide snow characterization of, 259 Butyl methacrylate, in patch testing, 136, in chemical peels, 257 commentary on, 253 138 in dermabrasion, 257 Chemotherapy, for melanoma, 108-109, Butyric acid, in nonallergic contact Carbonic washing fluid, in 323 urticaria, 206 photodermatitis, 238 Cheyletiella parasitovorax, in Carcinoma in situ, electrosurgery dermatitis, 171 C for, 287 Children C3 receptor, in allergic contact dermatitis, Carmustine, for melanoma, 323 giant congenital nevi in, 26-27 116 Carotenoids, for melanoma, 80 melanoma in, 17, 46 Cactaceae, in dermatitis, 171 Carswell, Robert, historical systemic lupus erythematosus in, 390 Cadmium description of melanoma by, 6 systemic scleroderma in, 414-415 in occupational skin granuloma, 220 Castor bean pomace, in Chinin-Idiosynkrasie, description of, 142 in photodermatitis, 238 immunologic contact urticaria, Chinoline mix, in patch testing, 197 Café-au-lait spots 206 Chloracetamide copper vapor laser therapy for, 295 Castor oil, in paint products, 186 in airborne allergic contact dermatitis, Q-switched ruby laser therapy for, 296 Caterpillars 126 Calcinosis, in scleroderma, 409-411 in airborne contact dermatitis, in paint products, 186 Calcium oxalate 125, 127-128 Chloracne in allergic contact dermatitis, 159 in nonallergic contact urticaria, as airborne contact dermatitis, 128 in irritant contact dermatitis, 158 206 characterization of, 214-215 Calcium silicate, in airborne contact Caucasians, melanoma in, 10-11, halogenated aromatic compounds in, dermatitis, 125 17, 43 214-215 Calibrated air plethysmography, in large Cautery, avoidance of, 382-383 therapy for, 216 vessel disease diagnosis, 374 CBA, see Crystallized bovine Chloramine, in immunologic contact Camphor, in paint products, 186 albumin urticaria, 206 Canada, melanoma in, 18, 43-46, 48, 76-78, CBS, see N-Cyclohexyl-2- Chloramphenicol 80, 91 benzothiazolyl sulfenamide in immunologic contact urticaria, 206 Clinics in Dermatology SUBJECT INDEX 487 1993;10:483-504 in occupational drug dermatitis, 142 Cisplatin, for melanoma, 323 pentagon-shaped full-thickness Chlorhexidine (Hibitane) Cistoran, in occupational drug resection, 269 in immunologic contact urticaria, 206 dermatitis, 141 pinch modification of linear in photodermatitis, 237 Citric acid, in irritant contact dermatitis, advancement flap, 268 in scalp reduction surgery, 348 158 Preven-A-Stik rack for surgical sharps Chloridazon (Pyrazon), in patch testing, c-jun oncogene, in melanoma, 35 in, 270 181 Cladonia spp., in allergic contact results from letter/form mailout to 131 Chlorine dermatitis, 159 dermatologists, 265-271 in immunologic contact urticaria, 206 CLE, see Cutaneous lupus erythematosus Stop Stix in, 270 in melanoma, 59-60 c-myb oncogene tissue transplantation (excluding hair Chloroacetophenone, in airborne allergic in melanoma, 36 and fat), 266-268, 270 contact dermatitis, 126 in systemic lupus erythematosus, treatment for specific problems, 266, p-Chlorobenzenesulfonylglycolic acid 390 268-269 nitrile, in occupational drug c-myc oncogene, in melanoma, 34-37 wound dressings, 267, 269 dermatitis, 143 CNP series antigens, in systemic Cold urticaria, characterization of, 207- Chloroprocaine scleroderma, 410 208 classification and clinical CNS, see Central nervous system Collagen diseases pharmacology of, 276 Coal tar, in photodermatitis, 238 commentary on, 387-388 history of, 275 Coal tar acne direct immunofluorescence in patients Chloroquine sulfate characterization of, 213-214 with, 423-428 in airborne allergic contact dermatitis, diagnosis of, 216 etiology of, 473-481 126 therapy for, 216 historical perspectives of, 393-396 in occupational drug dermatitis, 142 Cobalt Collagen injection Chlorothalonil, in patch testing, 180 in airborne allergic contact dermatitis, commentary on, 254 Chlorpromazine 126 in tissue augmentation, 260 in airborne allergic contact dermatitis, in paint products, 186 Colophony 126 in photodermatitis, 238 in airborne allergic contact dermatitis, in immunologic contact urticaria, 206 Cobalt chloride 126 Chlortetracycline, in occupational drug in nonallergic contact urticaria, 206 in paint products, 186 dermatitis, 142 in patch testing, 197 in patch testing, 197 Chondrodermatitis, cure of, 384 percentage incidence of, 151 percentage incidence of, 151 Chromates, in allergic contact dermatitis, sensitization to, 150 sensitization to, 150 115, 126-127 Cocaine, in topical anesthesia, 275, 277, Colorectal cancer, FAMM syndrome Chromosome 1, in melanoma, 33, 37 279 correlated with, 24 Chromosome 1p, in FAMM syndrome, Cockroach, in immunologic contact Complement factor deficiency 21, 24, 32-33 urticaria, 207 Ro/SS-A antibody in, 434 Chromosome 6, in melanoma, 32-34, 37 Coconut oil, in paint products, 186 in systemic lupus erythematosus, 389- Chromosome 7, in melanoma, 32-34, 37 Codeine, in occupational drug dermatitis, 390 Chromosome 8, in melanoma, 33-34 143 Complexion, in prediction of melanoma Chromosome 9, in melanoma, 33-34 Cod liver oil, in immunologic contact risk, 15 Chromosome 11 urticaria, 206 Compositae in melanoma, 32-35 Cold, ambient, in irritant contact in airborne allergic contact dermatitis, in Wilm’s tumor, 35 dermatitis, 118 126 Chromosome 19, in melanoma, 33, 35 Cold dermatosis, characterization of, 239- in allergic contact dermatitis, 158-160 Chronic actinic dermatitis, 240 sesquiterpenelactones in, 162 characterization of, 236 Cold steel surgery, recent advances in Compression Chronic disseminated discoid lupus basting suture application to center of for large varicose veins, 374 erythematosus (CDLE) graft, 270 after sclerotherapy for telangiectasia, immunologic findings in, 401-402 bilobed flap modifications, 268 377-378 within spectrum of systemic lupus Burow’s triangle excision, 270 Computerized scanning devices, in laser erythematosus, 402-403 crescentic flap, 268 surgery, 292 Chrysanthemum spp., in allergic contact dangers during operations, 267, 270 Condyloma accuminatum, 5-fluororacil dermatitis, 158, 207 donor site for full-thickness graft, 269 for, 306 Cinchocaine, in occupational drug drug therapy with surgery, 267, 270 Congenital hairy nevi, appearance of, 67 dermatitis, 141 excisions and primary closures, 265- Congenital lymphedema, liposuction in Cinnamate, in photodermatitis, 237 266 improvement of, 370 Cinnamic acid instruments and equipment, 266-267, Congenital nevi, as melanoma in contact urticaria, 160 269-271 precursors, 18, 21 in nonallergic contact urticaria, 206 intraoperative tissue expansion in, 269 Contact dermatitis, percentage Cinnamic aldehyde nose defect closed in, 268 distribution of incidence of in contact urticaria, 160 office-based cold steel surgery, 267, 270 various pathogenetic forms of, in nonallergic contact urticaria, 206 operative techniques, 265-267 150 488 SUBJECT INDEX Clinics in Dermatology 1993;10:483-504 Contact urticaria recommendations for, 383-384 Deep venous thrombosis, as aquagenic urticaria, 206 Cryotherapy, for lentigo maligna, 108 sclerotherapy complication, 374 classes of, 205-206 Crystallized bovine albumin (CBA), in Defatting flaps, liposuction for, 369-370 cold urticaria, 207-208 collagen disease, 395 Delayed type hypersensitivity, in allergic grading of by symptomatology, 206 c-sis oncogene, in melanoma, 35-36 contact dermatitis, 116-117 heat urticaria, 206 c-src oncogene, in melanoma, 35-36 Demerol, see Meperidine immunologic contact urticaria, 205- Cushing’s syndrome, buffalo hump Denmark 207 associated with, 369 giant congenital nevi in, 26 nonimmunologic contact urticaria, Cutaneous basophil hypersensitivity, in melanoma in, 9, 43-44, 46, 75-78, 80, 91 205-206 allergic contact dermatitis, 117 Deodorants, in airborne allergic contact plants in, 160 Cutaneous infections, occupational dermatitis, 126 solar urticaria, 207 bacterial infections, 225-227 Dercum’s disease, liposuction for, 369 undefined contact urticaria, 206 mycobacterial infections, 227 Dermabrasion Cooper, Samuel, historical description of mycotic infections, 227-228 characterization of, 257-258 melanoma by, 6 viral infections, 228-229 commentary on, 252-253 Copal, in paint products, 186 Cutaneous lupus erythematosus (CLE) Dermal epidermal junction, deposits at, Copper, serum, in melanoma, 80 clinical relevance of immunologic 399-400, 402 Copper sulfate, in patch testing, findings in, 399-405 Dermal-fat grafts, in tissue augmentation, 180 dermatologic criteria for classifying 260 Copper vapor laser, major forms of, 443-455 Dermanyssus spp., in dermatitis, 171 characterization of, 294-295 Cutting oils, in melanoma, 54 Dermatopathology, commentary on, 254 Copy paper, carbonless, in Cyanoacrylates Dermatophagoides pteronyssinus, in immunologic contact urticaria, in airborne allergic contact dermatitis, dermatitis, 171 207 126, 129 Dermoepidermal junction deposits, in Corals, in nonallergic contact chemistry of, 135 collagen diseases, 423, 425-428 urticaria, 206 industrial use of, 135 DETA, see Diethylenetriamine Cornstarch, in immunologic sensitization to, 135 Detergents contact urticaria, 207 Cycloaliphatic epoxy resins improper use of, 170 Corticosteroids industrial use of, 133 in irritant contact dermatitis, 118 in acne, 215 sensitization to, 134 in occupational skin granuloma, 221 in occupational drug Cyclohexane, in paint products, 186 DHE, see Dihematoporphyrin ether dermatitis, 143 N-Cyclohexyl-2-benzothiazoly] Dially! disulfide, as plant allergen, 161 in occupational skin sulfenamide (CBS), in 2,4-Diamino-6-chloromethylpteridine, in granuloma, 222 occupational contact dermatitis, occupational drug dermatitis, 142 Cosmetics 153 4,4’-Diaminodiphenylmethane (DDM) acne due to, 215 N-Cyclohexyl-N-phenyl-p- in occupational contact dermatitis, 154 in immunologic contact phenylenediamine (CPPD), in in patch testing, 134, 137, 197 urticaria, 206 occupational contact dermatitis, in photodermatitis, 238 Cotoneaster, in immunologic 153 sensitization to, 134, 150 contact urticaria, 207 Cyclosporin, melanoma in patients Diazepam Coumarin compounds, chemical treated with, 18 prior to punch hair transplantation, classification of, 177 Cytarabine, in occupational drug 337 CPPD, see N-Cyclohexyl-N- dermatitis, 142-143 prior to scalp reduction, 347 phenyl-p-phenylenediamine Cytokines Diazinon, in patch testing, 180 CR1 receptors, in systemic lupus in allergic contact dermatitis, 116, 245 Dibenzofurans, in chloracne, 128 erythematosus, 389 for melanoma, 324 Dibenzothiazolyl disulfide (DBD), in Crescentic flap, in cold steel Cytosine arabinoside, in occupational occupational contact dermatitis, surgery, 268 drug dermatitis, 142 153 o-Cresyl glycidyl ether (CGE) Dibrom, see Naled in patch testing, 134, 137 D Dibucaine personal data for, 136 Dacarbazine (DTIC), for melanoma, 108, in occupational drug dermatitis, 141 Croton oil 323 in topical anesthesia, 277 in irritant contact dermatitis, Dammar, in paint products, 186 Dibuty] phthalate, in patch testing, 136 118 Dander, in immunologic contact Dichlorvos (DDVP), in patch testing, 180 in melanoma, 72 urticaria, 207 Dietary factors, in etiology of melanoma, Croton spp., in irritant contact Dazomet, in patch testing, 181 79-81 dermatitis, 158 DBD, see Dibenzothiazoly] disulfide Diethyl-B-chloroethylamine, in CRT 20, in photodermatitis, 238 DCNB, see Dinitrochlorobenzene occupational drug dermatitis, 142 Cruciferae, in irritant contact DDLE, see Disseminated discoid lupus Diethylenetriamine (DETA) dermatitis, 160 erythematosus in patch testing, 134, 137 Cryosurgery DDM, see 4,4’-Diaminodiphenylmethane personal data for, 136 commentary on, 254 DDVP, see Dichlorovos sensitization to, 134 Clinics in Dermatology SUBJECT INDEX 489 1993;10:483-504 Diethyl phthalate, in patch testing, 136 Disperse yellow 3, in patch testing, 197 Electricity, occupational skin lesions Diethyltoluamide, in immunologic Disseminated discoid lupus caused by, 240-241 contact urticaria, 206 erythematosus (DDLE), Electrocoagulation, in electrosurgery, N,N-Diethylurea, in occupational contact classification of, 445-446, 450-451 286 dermatitis, 152 Disseminated morphea, antinuclear Electrodessication, in electrosurgery, 286 Diffenbachia spp., in irritant contact antibodies in, 416-417 Electrofulguration, in electrosurgery, dermatitis, 158 Distal wing block, in nail surgery, 285-286 Difolatan, see Captafol 327 Electrolysis, in electrosurgery, 286 O-Diglycidy! phthalate, sensitization to, Diterpenoid esters, in irritant contact Electronics industry, melanoma 134 dermatitis, 158 development correlated with Dihematoporphyrin ether (DHE), in Dithianon, in patch testing, 180 occupation in, 53-54 photosensitization, 297 Dithiocarbamates (DTCs), chemical Electrosection, in electrosurgery, Diisodecy] phthalate, in patch testing, 136 classification of, 176-177 286 Dimethoate, in patch testing, 180 Dithiocarbamide, in paint products, 186 Electrosurgery Dimethyl acetamide (DMA), in topical Diuretics, in occupational drug application of anesthesia, 278 dermatitis, 143 benign lesions, 287-288 7,12-Dimethylbenzanthracene (DMBA), DLE, see Discoid lupus erythematosus malignant tumors, 287-289 in melanoma, 58-59, 72 DMA, see Dimethyl acetamide vascular lesions, 289 Dimethylformamide, in melanoma, 52, 54 DMBA, see 7,12- verrucae, 288-290 Dimethyl sulfoxide (DMSO) Dimethylbenzanthracene biological hazards of in irritant contact dermatitis, 118 DMSO, see Dimethyl sulfoxide risks to medical personnel, in nonallergic contact urticaria, 206 DNOC, in patch testing, 181 287 in topical anesthesia, 278 Dogger Bank itch, as airborne allergic risks to patient, 287 Dimethylthiourea, in airborne allergic contact dermatitis, 126-127 electrodes used in high- contact dermatitis, 126 Domestic cleaning products, in airborne frequency electrosurgery, 286-287 Dimethyl-p-toluidine contact dermatitis, 125 modalities of in patch testing, 136 Doppler evaluations, in large vessel electrocoagulation, 286 sensitization to, 135 disease diagnosis, 374 electrodessication, 286 Dinitrochlorobenzene (DCNB), in allergic Dowager hump, liposuction for, 369 electrofulguration, 285-286 contact dermatitis, 115 DPPD, see N,N’-Dipheny]l-p- electrolysis, 286 Dinitrophenols, chemical classification of, phenylenediamine electrosection, 286 176-177 Droplets, in airborne contact dermatitis, high-frequency modalities, Dinitrotoluene, in photodermatitis, 238 123 285 Dinobuton, in patch testing, 181 Drugs Emetic substances, in Dinocap, in patch testing, 180 in airborne allergic contact dermatitis, occupational drug dermatitis, 143 Dioxins, in chloracne, 128 126 EMLA, in topical anesthesia, 278, Dipentamethylthiuram disulfide (PTD), in melanoma, 57-58 281, 294 in occupational contact dermatitis, DTCs, see Dithiocarbamates Endosulfan, in patch testing, 180 151-152 DTIC, see Dacarbazine England, melanoma in, 18, 48, 54, Diphenhydramine, in photodermatitis, Dubreuihl’s melanosis, in melanoma, 21 77, 85 237 Duplex scanning, in large vessel disease Environmental factors, in irritant N,N’-Dipheny]l-p-phenylenediamine diagnosis, 374 contact dermatitis, 118 (DPPD), in occupational contact Dyes, in airborne contact dermatitis, 125 Enzymes, proteolytic, in irritant dermatitis, 153 Dysplastic nevi contact dermatitis, 158 1,3-Diphenylguanidine, in occupational appearance of, 68 Epichlorohydrin contact dermatitis, 152 clinical features of, 22 in patch testing, 134 Dipyridinium compounds, chemical familial atypical multiple mole sensitization to, 133-134 classification of, 177 melanoma syndrome, 23-25 Epichlorydrin, in occupational Diquat, in patch testing, 181 histopathology of, 22-23 drug dermatitis, 142 Direct immunofluorescence, in clinically as melanoma precursors, 1-2, 18, 31, Epidermal growth factor (EGF), in healthy skin of patients with 46-47, 71 melanoma, 32-34, 37 collagen diseases, 423-428 Wilm’s tumor and, 35 Epidermatozoonosis, differential Discoid lupus erythematosus (DLE) diagnosis of, 170-171 antinuclear antibodies in, 424 E Epidian 3 and 5, in classification of, 445-446, 450-451 Ear, melanoma behind, 321 photodermatitis, 238 dermoepidermal junction deposits in, Eczema prurigo, differential diagnosis of, Epinephrine 427 170, 172 adverse reactions to, 281 vessel wall deposits in, 427 EDTA, see Ethylenediamine in infiltrative anesthesia, 279- Disinfectants, in occupational drug EGF, see Epidermal growth factor 280 dermatitis, 143 Elastolytic lupus erythematosus, in liposuction, 366 Disperse blue 124, in patch testing, 197 immunologic findings in, 403-404 in scalp reduction surgery, 348, Disperse red 1, in patch testing, 197 Electra pilosa, in photodermatitis, 238 353 490 SUBJECT INDEX Clinics in Dermatology 1993 ;10:483-504 in suction-assisted lipectomy, 361 Evernia spp., in allergic contact Fibrinoid necrosis, in collagen disease, Eponychial marsupialization, for chronic dermatitis, 159 395 recalcitrant paronychia, 328 Evernic acid, in allergic contact Ficin, in irritant contact dermatitis, 158 Epoxies, in paint products, 186 dermatitis, 159 Field block anesthesia, in scalp reduction Epoxy resins Exposure test, in diagnosis of airborne surgery, 348 in airborne contact dermatitis, 125-127 contact dermatitis, 129 Fig latex, in photodermatitis, 238 chemistry of, 133 Extractable nuclear antigens, historical Fingers, contractures of, in scleroderma, clinical features of, 134 perspective on, 395 409, 411 in immunologic contact urticaria, 206 Eye color, in prediction of melanoma risk, Firemen, melanoma development in, 53 industrial use of, 133 15 Fixed tissue technique, in Mohs in patch testing, 134, 137, 197 micrographic surgery, 311 personal data for, 136-137 F Flashlamp dye laser, characterization of, in photodermatitis, 237-238 Fabrics, in immunologic contact urticaria, 293-294 sensitization to, 133-134, 150 207 Flavones, in allergic contact dermatitis, Eruca spp., in irritant contact dermatitis, Facial syringomata, CO, laser therapy 159 158 for, 292 Fluorescent lights, in melanoma, 47-48 Erysipeloid, as occupational cutaneous Familial atypical multiple melanoma 5-Fluoracil infection, 226 (FAMM) syndrome adverse reactions to, 306 Erythema appearance of, 66, 68 application of, 305-306 copper vapor laser therapy for, 295 characterization of, 23-24 history of, 305 pulsed dye laser therapy for, 294 chromosome 1p in, 21, 24, 32-33 indications for, 306 Erythema multiforme-like eruptions, genetics of, 24-25, 31-34, 36-37 recent innovations in use of, 306-307 caused by tropical wood dust, 128 loss of heterozygosity in, 32-33 Foley catheters, in cold steel surgery, 269 Erythromycin, prior to punch hair management of FAMM families, 25 Folpet (Phaltan) transplantation, 337 Familial dysplastic nevus syndrome, see in contact dermatitis, 179 Erythroplasia of Queyrat, 5-fluororacil Familial atypical multiple in patch testing, 180 for, 306 melanoma syndrome Fontana’s argentaffin reaction, in melanin Esophagus, in scleroderma, 409-411 Family history, in prediction of localization, 332 Estriol, in melanoma, 77 melanoma risk, 17 Food additives, in airborne contact Estrogen cream, in immunologic contact FAMM, see Familial atypical multiple dermatitis, 125-126 urticaria, 206 mole melanoma syndrome Foods, in immunologic contact urticaria, Estrogen replacement therapy, in Famotidine, in occupational drug 207 melanoma, 77-78 dermatitis, 142 Foot, melanoma on, 320 Ethnicity, in prediction of melanoma risk, Fat, dietary, in melanoma, 80 Forearms, indurations up, in limited 17 Fat deposit diseases, liposuction for, scleroderma, 411 2-Ethoxyethyl methacrylate, in patch 369 Formaldehyde testing, 136 Fat necrosis, liposuction in evacuation of in airborne contact dermatitis, 125-126 Ethoxymethylmalodinitrile, in foci of, 370 in immunologic contact urticaria, 206 occupational drug dermatitis, 144 Feeder vessels, in small vessel in paint products, 186 Ethyl acetate, in paint products, 186 sclerotherapy, 375-377 in patch testing, 138, 197 Ethyl acrylate, in patch testing, 136 Fenticlor, in photodermatitis, 238 sensitization to, 150 Ethyl alcohol, in paint products, 186 Fentin hydroxide, in patch testing, 180 Formalin, percentage incidence of, 151 Ethylene, in paint products, 186 Fiberglass dermatitis Formic acid, in irritant contact dermatitis, Ethylenediamine (EDTA) characteristics of, 168-170 158 in occupational contact dermatitis, 154 diagnosis of, 170 Fortemustine, for melanoma, 323 in patch testing, 134 differential diagnosis of, 170-172 Fragrances, in airborne allergic contact sensitization to, 150 pathogenic mechanisms of, 169 dermatitis, 126-127 Ethylenediamine dihydrochloride, in perivascular accumulation of France, melanoma in, 17 patch testing, 197 lymphocytes in superficial Freckling Ethylene glycol dimethacrylate, in patch dermis, 170 copper vapor laser therapy for, 295 testing, 136, 138 prevention of, 172-173 in prediction of melanoma risk, 16 Ethylene glyconitrate, in rash in, 169 Free-fat grafts, in tissue augmentation, photodermatitis, 238 technical commodities and, 167-168 260 Ethyl hexyl acrylate, in patch testing, 136 therapy for, 172-173 Fresh tissue technique, in Mohs Ethyl methacrylate, in patch testing, 136 Fiber manufacture industry, melanoma micrographic surgery, 311-312 Etidocaine, classification and clinical development correlated with Friction, in occupational dermatitis, 232- pharmacology of, 276 occupation in, 54 233 Euphorbia spp., in irritant contact Fiberglass dermatitis, as airborne irritant Frullania spp. dermatitis, 158, 160 contact dermatitis, 125 in airborne allergic contact dermatitis, Europe, melanoma in, 1, 41, 75-76 Fibrel, in tissue augmentation, 260 126 Eve, Frederick, historical description of Fibrillarin antibody, in systemic in allergic contact dermatitis, 158-159, melanoma by, 7 scleroderma, 408, 410, 413, 415 163 Clinics in Dermatology SUBJECT INDEX 491 1993;10:483-504 sesquiterpenelactones in, 162 corticosteroid dust in, 222 sclerotherapy complication, 375 Fumigants definition of, 219 Henna, in immunologic contact urticaria, chemical classification of, 177 foreign-body, 219-222 206 in patch testing, 181 iatrogenous origin of, 222 Hepatitis B virus (HBV), transmission of Fungicides infectious granuloma, 220-221 during electrosurgery, 287 chemical classification of, 176 significant types of, 219-220 Heptane, in paint products, 186 in patch testing, 180 treatment of, 222 Heradeum spondylium, in photodermatitis, Furaltadone, in occupational drug Grazer suction-assisted lipectomy 238 dermatitis, 143 procedure, for axillary Herbicides Furazolidone, in occupational drug hyperhidrosis, 359-363 chemical classification of, 176-177 dermatitis, 143 GSH, see Glutathione in patch testing, 181 Furocoumarins, in photodermatitis, 160 Guinea pig, in immunologic contact Herpes gladiatorum, as occupational Furosemide, in photodermatitis, 237 urticaria, 207 cutaneous infection, 229 Herpes whitlow, as occupational Gut, in immunologic contact urticaria, 207 cutaneous infection, 228 GVHKR, see Graft versus host reaction Hexachlorophene, in photodermatitis, G Gynecomastia, liposuction for, 369 237 Galeotomies, for scalp reduction, 348 Hexamethylenetetramine, in Gangrene, as sclerotherapy complication, occupational contact dermatitis, 374 154 Garlic, in allergic contact dermatitis, 159- H Hexanediol diacrylate, in patch testing, 160 Hair, in immunologic contact urticaria, 136 Gases, in airborne contact dermatitis, 123 207 Hexascan scanner, computerized, 292 Gastric acidity agents, in occupational Hair color, in prediction of melanoma Hibitane, see Chlorhexidine drug dermatitis, 141 risk, 15 High-frequency modalities, in Gastrointestinal tract cancers, FAMM Hair restoration, characterization of, 258- electrosurgery, 285 syndrome correlated with, 24 259 Hippomane spp., in irritant contact GD3 asialoganglioside, in melanoma, 69- Hair sprays dermatitis, 158 70 in airborne allergic contact dermatitis, Hispanics, melanoma in, 17 Generalized morphea, antinuclear 126 Histamine, in contact urticaria, 160 antibodies in, 416-417 in immunologic contact urticaria, 206 Histone, in systemic lupus Genital Bowenoid papulosis, 5-fluororacil Hair transplantation, commentary on, erythematosus, 391 for, 306 253-254 HIV, see Human immunodeficiency virus Gentamicin Halliday, Andrew, historical description HIV-1, see Human immunodeficiency in immunologic contact urticaria, 206 of melanoma by, 6 virus type 1 in occupational drug dermatitis, 142 Halogenated aromatic compounds, in HIV-2, see Human immunodeficiency Germany, melanoma in, 85 chloracne, 214-215 virus type 2 Gestagens, in melanoma, 76 Halogenated compounds, in airborne HLA antigens, in systemic scleroderma, Giant congenital nevi, characterization of, allergic contact dermatitis, 126 415 26-27 Halogenated hydrocarbons, chemical HLA genes, in melanoma, 34, 36 Glanders, as occupational cutaneous classification of, 177 HLA-DR(la) molecules, in allergic contact infection, 226 Haptens dermatitis, 116 Glass fibers, in airborne contact in occupational contact dermatitis, 151, HLA-DR3 gene, in systemic lupus dermatitis, 125 153-154 erythematosus, 390 Gloves, protective, against occupational percentage incidence of, 151 Hodgkin's disease contact dermatitis, 190-191 Hatacide LP5, in photodermatitis, 238 differential diagnosis of, 172 Glutathione (GSH) HBV, see Hepatitis B virus melanoma associated with, 70-71, 83 in photodermatitis, 160 HCH, see Lindane Honduras, melanoma in, 85 reduced, for melanoma, 80 Health care workers, HIV risk to, 202 Horizontal sectioning, in Mohs Glycidyl ether compound diluents, Heart, in scleroderma, 409, 411 micrographic surgery, schematic sensitization to, 134 Heat, skin lesions caused by, 241-242 representation of, 310 Glycols, in paint products, 186 Heat urticaria, characterization of, 206 Horse serum, in immunologic contact Glycosides, in irritant contact dermatitis, Helium neon laser, characterization of, urticaria, 206 158 298-299 HpD, see Hematoporphyrin derivative Glycyphagus domesticus,in dermatitis, 171 Hemangiomas H-ras oncogene, in melanoma, 36 Glyphosate, in patch testing, 181 copper vapor laser therapy for, 295 hst/int-2 locus, in melanoma, 35-36 Gottron’s papules, in scleromyositis, 460 pulsed dye laser therapy for, 294 Human immunodeficiency virus (HIV) Graft versus host reaction (GVHR), in Hematomas, liposuction in evacuation of electrosurgery and, 287 scleroderma, 417-418 foci of, 370 health care worker exposure to, 202 Granulomas, occupational skin Hematoporphyrin derivative (HpD), in melanoma associated with, 71, 83 allergic, 219-222 photosensitization, 297 risk of acquiring infection at work, anecdotal cases of, 222 Hemosiderotic hyperpigmentation, as 201-202 492 SUBJECT INDEX Clinics in Dermatology 1993 ;10:483-504 risk of transmitting infection at work, Immunofluorescence, historical IPPD, see N-Phenyl-N-isopropyl-p- 202-203 perspective on, 394-395 phenylenediamine scleroderma and, 407 Immunologic contact urticaria, Ireland, melanoma in, 17 toxicity of work to employees infected characterization of, 205-207 Irritant contact dermatitis with, 203 Immunologic effects, of ultraviolet action of irritants in, 118 Human immunodeficiency virus type 1 radiation, 71-72 endogenous factors in, 117-118 (HIV-1), melanoma associated Immunoregulation environmental factors in, 118 with, 57 in allergic contact dermatitis, 117 pesticides in, 178 Human immunodeficiency virus type 2 in cutaneous lupus erythematosus, plants in, 158, 160 (HIV-2), melanoma associated 399-404 rubber in, 149-150 with, 57 in melanoma, 69-73 Isobutyl acrylate, in patch testing, 136 Humidity, ambient Immunosuppression, in melanoma, 18, Isocyanates, in paint products, 186 in airborne contact dermatitis, 129 70-71, 83 Isocyanines, in paint products, 186 in irritant contact dermatitis, 118 Immunotherapy, in melanoma Isolation perfusion, in melanoma Hunter, John, historical description of management, 70, 108-109 management, 108 melanoma by, 5 India, melanoma in, 17, 85 Isophoronediamine (IPDA) Hutchinson, Jonathan, historical Indurative edema, in scleroderma, 409, 411 in patch testing, 134, 137 description of melanoma by, 6 Industrial dermatitis, see Occupational personal data for, 136-137 Hutchinson's melanotic freckle, in contact dermatitis sensitization to, 134 melanoma, 21 Industrial solvents, in airborne contact Isopropyl ether, in paint products, 186 Hyaluronidase, in liposuction, 366 dermatitis, 125 Isothiazoline derivatives, in paint Hydrocortisone, in photodermatitis, 237 Infiltrative anesthesia, advances in, 279- products, 186 Hydroquinone, sensitization to, 135 280 Israel, melanoma in, 17, 91 Hydroquinone monobenzyl ether Infrared radiation, in occupational Italy, melanoma in, 75-77, 85, 93 in occupational contact dermatitis, 154 dermatitis, 239 in patch testing, 136 Inorganic compounds, chemical J Hydroxyethy] acrylate, in patch testing, classification of, 176 Japan, melanoma in, 17, 46 136 Insecticides Jellyfish, in nonallergic contact urticaria, Hydroxyethyl methacrylate, in patch in airborne allergic contact dermatitis, 206 testing, 136 126 Jo-1 antibody, in scleroderma/ Hydroxypropyl methacrylate, in patch chemical classification of, 176 polymyositis overlap syndromes, testing, 136 in patch testing, 180 464-470 5-Hydroxytryptamine, in contact Insect repellents, in immunologic contact jun oncogenes, in melanoma, 35 urticaria, 160 urticaria, 206 Hylesia urticans, in airborne allergic Insects, in immunologic contact urticaria, K contact dermatitis, 128 207 Kanamycin, in occupational drug Hyperirritable skin, in irritant contact Insulin receptor gene, in melanoma, 35 dermatitis, 142 dermatitis, 117-118 Intercellular adhesion molecule 1 (ICAM- Kaposi's sarcoma, photodynamic laser Hypertrophic insulin lipodystrophy, 1), in allergic contact dermatitis, therapy for, 298 liposuction for, 369 116, 162, 245 Kathon GG, in patch testing, 197 Interdigital pilonidal sinus, as Keratoacanthomas I occupational dermatitis, 221 bleomycin for, 384 ICAM-1, see Intercellular adhesion Interferon (IFN), for melanoma, 324 molecule 1 Interferon-y (IFN-y), in allergic contact 5-fluororacil for, 306 Keratoses IFN, see Interferon dermatitis, 116 copper vapor laser therapy for, 295 IFN-y, see Interferon-y Interferons, in allergic contact dermatitis, IgG in melanoma, 67 245 Ketocaine, in topical anesthesia, 278 in Sjogren’s syndrome, 425 Interleukin 1 (IL-1), in allergic contact Ketones, in paint products, 186 in systemic lupus erythematosus, 425 dermatitis, 116, 245 Ketoprofen, in photodermatitis, 237 IgG anticardiolipin antibodies, in Interleukin 2 (IL-2) Kidney, in scleroderma, 409, 411 systemic lupus erythematosus, in allergic contact dermatitis, 116, 245 391 in melanoma, 70, 108-109, 324 Kitasamycin, in occupational drug IgM, in systemic lupus erythematosus, Interleukin 4 (IL-4), in allergic contact dermatitis, 142 391 dermatitis, 245 Koebner’s sign, in occupational IL-1, see Interleukin 1 Interstitial lung disease, systemic lupus dermatitis, 233 IL-2, see Interleukin 2 erythematosus with, as anti-Ro K-ras oncogene, in melanoma, 36 IL-4, see Interleukin 4 syndrome, 390 KTP laser, characterization of, Imidazole-thio-ether-aminoithiols, in Intestine, melanoma metastasis to, 292-293 occupational drug dermatitis, 142 323 Imidazolidinylurea Ionizing radiation, in occupational L in patch testing, 197 dermatitis, 234-236 Labetalol, in occupational drug sensitization to, 150 IPDA, see Isophoronediamine dermatitis, 142